GLP-1 Frequently Asked Questions
Summary: Direct, plain-language answers to the questions patients ask most often about GLP-1 medications, covering effectiveness, side effects, dosing, lifestyle, safety, stopping, logistics, compounded options, medical concerns, and cost.
This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.
Effectiveness and weight loss
How fast does Ozempic start working?
Blood sugar effects often appear within the first week, but meaningful weight changes usually take 4 to 8 weeks while the dose escalates from the 0.25 mg starter to 1 mg or 2 mg [1][2]. In the 68-week STEP 1 trial, average weight loss on semaglutide reached about 15 percent of body weight, with most participants showing a clear downward trend by month 3 [3]. Appetite suppression and the "food noise" quieting often kick in within the first two doses, even before the scale moves much.
How much weight will I lose on a GLP-1?
Average loss in pivotal trials was about 15 percent of starting body weight on semaglutide 2.4 mg over 68 weeks, and about 21 percent on tirzepatide 15 mg over 72 weeks in SURMOUNT-1 [3][11]. Real-world results vary widely depending on the dose tolerated, diet quality, activity level, baseline weight, and how long you stay on therapy. About one in three patients hits 20 percent or more on tirzepatide, and a smaller subset lose much less than the average even at maximum doses.
Why am I not losing weight on a GLP-1?
Common reasons are still being in the low starter doses, eating around the appetite suppression with liquid calories or grazing, inadequate protein, poor sleep, alcohol, or another medication that promotes weight gain (steroids, some antidepressants, beta blockers) [12]. Hormonal conditions like hypothyroidism or PCOS can also blunt response and are worth screening if labs are due. About 10 to 15 percent of patients are non-responders even at the maximum dose, and switching from semaglutide to tirzepatide often helps that group.
When will I hit a weight loss plateau?
Most people plateau between months 9 and 14 once metabolism adapts to the lower body weight and daily energy needs drop [12]. Hitting a plateau is biology, not failure: smaller bodies burn fewer calories, and appetite begins to creep back as adaptive hormones rise. Strategies include reaching the maximum tolerated dose, prioritizing protein and resistance training, tracking intake for a week to spot drift, ruling out fluid shifts, and discussing whether to switch molecules with your prescriber.
What is the difference between Ozempic, Wegovy, Mounjaro, and Zepbound?
Ozempic and Wegovy are both semaglutide from Novo Nordisk; Ozempic is approved for type 2 diabetes up to 2 mg weekly and Wegovy is approved for chronic weight management up to 2.4 mg [1][13]. Mounjaro and Zepbound are both tirzepatide from Eli Lilly, a dual GLP-1/GIP agonist; Mounjaro is for diabetes and Zepbound for weight loss, both up to 15 mg weekly [11]. Tirzepatide produces somewhat larger average weight loss than semaglutide in head-to-head trials, but tolerability and insurance coverage often decide the choice.
Will a GLP-1 work without diet and exercise?
Yes, you will lose weight on the medication alone, but results are larger and more durable when paired with a higher-protein diet and resistance training [4]. Without exercise, a meaningful share of weight loss can come from muscle, which slows metabolism and makes regain easier if you ever stop the medication.
Side effects and tolerability
What are the most common side effects?
Nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, headache, and burping affect more than 5 percent of patients in trials [1][14]. Most are mild to moderate and concentrated in the first weeks after starting and after each dose increase, then ease as the gut adapts. Injection-site reactions, dizziness, and a metallic taste are also reported but usually brief.
How long do GLP-1 side effects last?
Gastrointestinal symptoms usually peak in the first 1 to 4 days after a dose increase and ease within 2 to 4 weeks at a stable dose [4]. If nausea or vomiting persists past a month at the same dose, your prescriber may delay the next escalation, step you down, or switch molecules. Severe or worsening symptoms, especially abdominal pain, vomiting that prevents drinking fluids, or signs of dehydration, warrant a same-day call.
Is "Ozempic face" real?
Ozempic face describes the gaunt, hollow look that can follow rapid weight loss because facial fat pads shrink along with body fat [4]. The medication itself does not target the face; the same change happens with bariatric surgery or aggressive dieting. Slowing the rate of loss, protecting muscle with resistance training, and adequate protein and hydration help; cosmetic options like dermal filler or fat grafting are common after large losses.
Will I lose muscle on a GLP-1?
Studies suggest 25 to 40 percent of total weight lost on semaglutide is lean mass, similar to caloric restriction without medication [3]. Resistance training 2 to 3 times a week and 1.2 to 1.6 grams of protein per kilogram of body weight per day substantially reduce that loss and protect long-term metabolic health. Some lean mass loss is water and the structural tissue that supports the lost fat, so the loss is not all functional muscle.
Does Ozempic cause hair loss?
Hair shedding is not on the Ozempic label but appears in Wegovy trials at about 3 percent of patients versus 1 percent on placebo [10]. The likely mechanism is telogen effluvium from rapid weight loss rather than a direct drug effect, and shedding usually resolves within 6 months once weight stabilizes and protein intake is adequate. Iron, ferritin, vitamin D, zinc, and thyroid labs are reasonable to check if shedding is heavy or persists past 9 months.
Does a GLP-1 cause depression?
FDA reviews and large observational studies through 2024 have not confirmed an increased risk of depression or suicidal ideation on semaglutide or tirzepatide compared to other weight loss treatments [15]. Some early case reports prompted formal review, but signal investigation has not borne out a causal link. Patients with a history of mood disorders should still tell their prescriber and watch for changes in mood, sleep, or motivation after starting or escalating.
Is long-term use of GLP-1 medications safe?
Liraglutide has been on the U.S. market since 2010 and semaglutide since 2017, with multi-year cardiovascular outcome trials such as SUSTAIN-6, LEADER, and SELECT supporting safety in diabetes and high-risk adults [6]. Long-term monitoring still matters for thyroid, gallbladder, pancreas, and kidney signals, and there is a boxed warning about medullary thyroid carcinoma in people with MEN2 or a personal/family history of MTC.
Dosing
What if I miss a weekly dose?
If 5 days or fewer have passed since your scheduled Ozempic or Wegovy injection, take it as soon as you remember, then continue your usual weekly schedule [1][2]. If more than 5 days have gone by, skip the missed dose entirely and take the next one on its normal day. Never double up to "catch up," and you can shift the weekly day permanently as long as at least 48 hours separate two doses.
Can I skip a week on a GLP-1?
Skipping one week is generally safe but appetite often returns and GI side effects can reappear when you resume the same dose [1]. Skipping more than two consecutive weeks at higher doses usually means stepping back down to the previous dose for a couple of weeks to avoid intense nausea.
Why do I have to titrate the dose up?
The slow ramp from 0.25 mg up to 2 mg semaglutide, or 2.5 mg up to 15 mg tirzepatide, gives the gut time to adapt to delayed emptying [1][11]. Skipping titration causes severe nausea, vomiting, and dehydration in most patients and rarely improves long-term weight loss. The starter doses are deliberately sub-therapeutic for weight loss; the goal is just to get you through the adjustment window without quitting.
When can I increase my dose?
Standard schedules increase every 4 weeks if side effects are tolerable, but many clinicians extend that to 6 to 8 weeks if nausea is still present [2]. Staying longer at a lower dose does not reduce eventual weight loss, and lower maintenance doses sometimes work as well as the maximum.
Lifestyle
Can I drink alcohol on a GLP-1?
Light, occasional drinking is generally tolerated, but alcohol can amplify nausea, worsen reflux, dehydrate you, and raise the risk of low blood sugar if you also take insulin or a sulfonylurea [4]. Many patients report that one or two drinks feel noticeably stronger because slowed stomach emptying changes how alcohol is absorbed. A smaller sub-group lose interest in alcohol entirely, an effect now under formal study for alcohol use disorder.
What should I eat on a GLP-1?
Aim for lean protein at every meal (chicken, fish, Greek yogurt, eggs, tofu, beans), non-starchy vegetables, fruit, and slow carbohydrates like oats and quinoa [4][12]. Eat slowly, stop at the first sense of fullness, and split meals if portions feel too large; intake naturally drops without willpower work.
What foods should I avoid?
Greasy fried foods, very rich desserts, heavy cream sauces, large meat portions, carbonated drinks, and high-fat takeout most often trigger nausea, reflux, and burping because the medication slows stomach emptying [4]. Most patients learn their personal triggers within the first month and adjust portions accordingly.
How much water should I drink?
Aim for at least 2 to 2.5 liters (about 64 to 80 ounces) per day to offset reduced thirst, prevent constipation, and protect kidney function [12]. People who exercise, live in hot climates, or drink coffee need more, and electrolyte drinks help if intake drops sharply in the first weeks. Sip throughout the day instead of front-loading, since large volumes at once can worsen nausea.
Should I take vitamins on a GLP-1?
A daily multivitamin plus 1000 to 2000 IU vitamin D and 200 to 400 mg magnesium covers the most common gaps when food intake drops [12]. Iron, B12, and protein are worth checking yearly, especially in menstruating women and anyone also on metformin. A protein supplement (whey, soy, or pea, 20 to 30 grams once or twice a day) is the single most useful addition for muscle preservation.
Safety and contraindications
Who should not take a GLP-1?
GLP-1s are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or MEN2, and in people with prior serious hypersensitivity to the drug [1][7]. They are also not recommended in pregnancy or breastfeeding, in active pancreatitis, or in type 1 diabetes (where they are not approved).
Can I take a GLP-1 with my other medications?
GLP-1s are generally compatible with most prescriptions, but slowed gastric emptying can change the timing and absorption of oral drugs, and combining with insulin or a sulfonylurea raises hypoglycemia risk [1][7]. Tell your prescriber about thyroid medication, blood thinners, oral contraceptives, antidepressants, and any oral diabetes drugs. Levothyroxine in particular may need a dose adjustment after significant weight loss because TSH targets shift.
Does a GLP-1 interact with birth control?
Tirzepatide can reduce absorption of oral contraceptives by up to 20 percent at the time of dose escalation; Lilly recommends a barrier method or switching to a non-oral form for 4 weeks after each tirzepatide dose increase [11]. Semaglutide has not shown the same effect, although missed pills due to vomiting are still a real risk.
Can I take a GLP-1 during pregnancy?
No. Animal studies show fetal harm and there is no controlled human safety data for semaglutide, tirzepatide, or liraglutide [1][7]. Manufacturers advise stopping semaglutide at least 2 months before trying to conceive because of its long half-life of about 1 week.
Can I take a GLP-1 while breastfeeding?
No human safety data exist and the drugs are not recommended during breastfeeding [1]. Discuss alternatives with your prescriber and lactation consultant if you need treatment for diabetes or obesity in the postpartum period.
Can I take a GLP-1 before surgery?
The American Society of Anesthesiologists recommends holding weekly GLP-1s for 1 week and daily forms for the day of elective surgery to reduce the risk of food remaining in the stomach and being aspirated under anesthesia [16]. Tell your surgeon and anesthesiologist what you take and when you took the last dose. For urgent procedures the team may use ultrasound to assess gastric contents or treat you as a full stomach.
Stopping and regain
What happens when I stop taking a GLP-1?
Appetite returns within a few weeks and weight typically rebounds. The STEP 1 extension trial found participants regained roughly two-thirds of their lost weight within a year of stopping semaglutide [3][5]. Blood sugar in people with type 2 diabetes also drifts back toward pre-treatment levels.
Will I gain the weight back if I stop?
Most people do, unless they have built durable diet, activity, and sleep habits during treatment [5]. Obesity is a chronic condition, and clinicians increasingly think of GLP-1s as long-term therapy rather than a short course, much like medication for hypertension or cholesterol.
Can I stay on a GLP-1 forever?
Long-term use is supported by years of safety data and is now common in clinical practice [6]. Many patients drop to a lower maintenance dose (for example, 1 mg semaglutide or 5 mg tirzepatide) once they hit their goal weight rather than stopping outright, which preserves much of the weight loss. The right duration is individual and worth revisiting yearly with your prescriber alongside labs and a benefit/risk discussion.
Practical and logistics
How do I store the Ozempic or Wegovy pen?
Store unopened pens in the refrigerator at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius) [2][13]. Once in use, the Ozempic pen can sit at room temperature between 59 and 86 degrees Fahrenheit (15 to 30 degrees Celsius) or stay refrigerated for up to 56 days; Wegovy is rated for 28 days at room temperature. Never freeze the pen and never share it, even with a new needle.
Can I travel with a GLP-1?
Yes. Carry pens in their original packaging in your carry-on, use a small insulated bag with a gel pack to keep them cool but not frozen, and bring a copy of your prescription [2]. TSA and most international airports allow injectable medications without restriction, and time-zone shifts of a few hours rarely affect a weekly schedule.
Compounded specifics
Is compounded semaglutide or tirzepatide safe?
The FDA has warned repeatedly that compounded versions are not reviewed for safety, efficacy, or quality, and has documented dosing errors, mislabeling, and adverse events [9]. With both semaglutide and tirzepatide off the FDA drug shortage list in 2025, large-scale compounding under sections 503A and 503B is no longer broadly permitted.
How is compounded different from brand?
Brand pens contain semaglutide or tirzepatide manufactured under FDA-inspected conditions with consistent dose delivery and full clinical trial support [1][11]. Compounded vials are mixed by a pharmacy, sometimes with additives like B12 or different salt forms (such as semaglutide sodium) that have never been tested for safety or efficacy in humans. Active ingredient concentrations and impurity profiles can vary lot to lot, which is the FDA's main concern [9].
Medical concerns
Does a GLP-1 cause pancreatitis?
Acute pancreatitis is listed as a rare but serious adverse reaction, occurring in roughly 0.1 to 0.2 percent of patients in clinical trials [7]. Severe persistent abdominal pain that radiates to the back, with or without vomiting, is a warning sign and means stopping the medication and seeking urgent care. People with prior pancreatitis or heavy alcohol use should discuss alternatives with their prescriber before starting.
Does a GLP-1 cause gallstones?
Yes; rapid weight loss of any kind raises gallstone risk, and trials show roughly 1.6 to 2.6 percent of GLP-1 patients develop gallbladder problems versus 0.4 percent on placebo [7]. Slower weight loss, adequate hydration, and meals containing some fat help reduce risk. Right upper abdominal pain after meals, especially fatty ones, is the classic symptom and deserves a call to your prescriber.
Does a GLP-1 cause thyroid cancer?
Rodent studies showed thyroid C-cell tumors with GLP-1 drugs, which led to a boxed warning, but human registries through 2024 have not shown an increased rate of medullary thyroid carcinoma in patients [1][7]. The drugs remain contraindicated in anyone with a personal or family history of MTC or MEN2 syndrome. Routine thyroid screening is not required, but a new persistent neck lump or hoarseness should be evaluated.
Does a GLP-1 cause constipation or diarrhea?
Both are common, with constipation affecting about 3 to 5 percent and diarrhea about 8 percent of patients in trials [1][14]. Hydration, fiber from vegetables and fruit, magnesium 200 to 400 mg at night, and a daily walk usually keep things moving; over-the-counter polyethylene glycol works for stubborn cases. Diarrhea typically settles within days; if it persists past a week or contains blood, contact your prescriber.
Why am I burping more on a GLP-1?
Sulfur-tasting burps are a hallmark of GLP-1 therapy, especially on tirzepatide, because slowed gastric emptying allows food to ferment briefly in the stomach before it moves on [11][14]. Smaller portions, lower-fat meals, slower eating, peppermint tea, and avoiding carbonated drinks usually cut frequency within a couple of weeks. Persistent foul belches that come with new pain or vomiting are worth a call to your prescriber.
Cost and access
How much does a GLP-1 cost without insurance?
U.S. list prices are roughly 1000 to 1350 dollars per month for Ozempic, Wegovy, Mounjaro, and Zepbound [17]. Manufacturer self-pay programs (NovoCare for Wegovy, LillyDirect for Zepbound) and direct-to-consumer vials have brought cash prices for some patients down to about 350 to 500 dollars per month in 2025 and 2026. Prices vary by dose, pharmacy, and whether you can pick up a 90-day supply at once.
Does insurance cover Ozempic, Wegovy, or Zepbound?
Most commercial plans cover Ozempic and Mounjaro for type 2 diabetes when criteria like A1C threshold and prior metformin use are met [8]. Coverage for Wegovy and Zepbound for weight loss is far more variable; Medicare currently covers GLP-1s only for diabetes or for adults with established cardiovascular disease and obesity under a 2024 CMS update.
What if my insurance denies coverage?
Ask your prescriber to file a prior authorization with documentation of your BMI, comorbidities, and prior weight loss attempts, then appeal a denial in writing within the timeframe in your denial letter [8]. Manufacturer savings cards, patient assistance programs, and direct-to-consumer vials from NovoCare and LillyDirect are common backup paths for cash-pay patients. External review through your state's insurance department is a final step if internal appeals fail and the denial seems inconsistent with plan documents.
References
- Novo Nordisk. Ozempic (semaglutide) Prescribing Information. Available at: novo-pi.com/ozempic.pdf
- Ozempic.com. Frequently Asked Questions: Ozempic Pen. Available at: ozempic.com/faqs/ozempic-pen.html
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021;384:989-1002.
- Healthline. Ozempic: Uses, Dosage, Side Effects. Available at: healthline.com/health/drugs/ozempic
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide (STEP 1 extension). Diabetes, Obesity and Metabolism. 2022;24:1553-1564.
- Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine. 2023;389:2221-2232.
- Cleveland Clinic. GLP-1 Agonists. Available at: my.clevelandclinic.org/health/treatments/13901-glp-1-agonists
- Centers for Medicare & Medicaid Services. Coverage of Anti-Obesity Medications and GLP-1 Receptor Agonists. CMS guidance, 2024.
- U.S. Food & Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Available at: fda.gov
- Novo Nordisk. Wegovy (semaglutide) Prescribing Information, Adverse Reactions section.
- Eli Lilly. Mounjaro and Zepbound (tirzepatide) Prescribing Information. Available at: lilly.com
- AMCP. Frequently Asked Questions on GLP-1 Medications. Available at: amcp.org/resource/glp-1-faq
- Wegovy.com. Wegovy FAQs. Available at: wegovy.com/obesity/starting-wegovy/faq.html
- Mayo Clinic. Semaglutide (subcutaneous route) Side Effects. Available at: mayoclinic.org
- U.S. Food & Drug Administration. Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking GLP-1 medications. 2024.
- American Society of Anesthesiologists. Consensus-Based Guidance on Preoperative Management of Patients on GLP-1 Receptor Agonists. ASA, 2023.
- GoodRx. Wegovy and Zepbound Cost and Savings. Available at: goodrx.com/wegovy